| Understanding the role of advanced practice providers in oncology in the United States SS Bruinooge, TA Pickard, W Vogel, A Hanley, C Schenkel, ... Journal of Oncology Practice 14 (9), e518-e532, 2018 | 102 | 2018 |
| A call to action: Ethics committee roundtable recommendations for addressing burnout and moral distress in oncology FJ Hlubocky, LP Taylor, JM Marron, RA Spence, MM McGinnis, RF Brown, ... JCO Oncology Practice 16 (4), 191-199, 2020 | 60 | 2020 |
| National Study of Burnout and Career Satisfaction Among Physician Assistants in Oncology: Implications for Team-Based Care ED Tetzlaff, HM Hylton, L DeMora, K Ruth, YN Wong Journal of oncology practice 14 (1), e11-e22, 2017 | 56 | 2017 |
| Hepatic arterial infusion of floxuridine and dexamethasone plus high‐dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma N Kemeny, A Eid, J Stockman, M Gonen, L Schwartz, E Tetzlaff, P Paty Journal of surgical oncology 91 (2), 97-101, 2005 | 51 | 2005 |
| Review of docetaxel in the treatment of gastric cancer ED Tetzlaff, JD Cheng, JA Ajani Therapeutics and clinical risk management 4 (5), 999-1007, 2008 | 46 | 2008 |
| The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma ED Tetzlaff, AM Correa, J Baker, J Ensor, JA Ajani Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 40 | 2007 |
| Optimal avapritinib treatment strategies for patients with metastatic or unresectable gastrointestinal stromal tumors CP Joseph, SN Abaricia, MA Angelis, K Polson, RL Jones, YK Kang, ... The Oncologist 26 (4), e622-e631, 2021 | 34 | 2021 |
| Dose escalating study of crenolanib besylate in advanced GIST patients with PDGFRA D842V activating mutations. M von Mehren, ED Tetzlaff, M Macaraeg, J Davis, V Agarwal, ... Journal of Clinical Oncology 34 (15_suppl), 11010-11010, 2016 | 32 | 2016 |
| Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction ED Tetzlaff, AM Correa, R Komaki, SG Swisher, D Maru, WA Ross, ... Diseases of the Esophagus 21 (7), 575-581, 2008 | 30 | 2008 |
| Multistate models: accurate and dynamic methods to improve predictions of thrombotic risk in patients with cancer A Carmona-Bayonas, P Jimenez-Fonseca, M Garrido, A Custodio, ... Thrombosis and Haemostasis 119 (11), 1849-1859, 2019 | 27 | 2019 |
| Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer M Cole, S Parajuli, D Laske, L Goldstein, T Morrison, A Mukherjee, ... The American Journal of Case Reports 15, 294, 2014 | 24 | 2014 |
| Creating a blueprint of well-being in oncology: an approach for addressing burnout from ASCO’s clinician well-being taskforce FJ Hlubocky, TD Shanafelt, AL Back, JA Paice, ED Tetzlaff, CR Friese, ... American Society of Clinical Oncology Educational Book 41, e339-e353, 2021 | 20 | 2021 |
| Phase I/II trial of docetaxel plus oxaliplatin and 5-fluorouracil (D-FOX) in patients with untreated, advanced gastric or gastroesophageal cancer JA Ajani, A Phan, L Ho, ED Tetzlaff, J Baker, Q Wei Journal of Clinical Oncology 25 (18_suppl), 4612-4612, 2007 | 18 | 2007 |
| Changes in burnout among oncology physician assistants between 2015 and 2019 ED Tetzlaff, HM Hylton, KJ Ruth, Z Hasse, MJ Hall JCO Oncology Practice 18 (1), e47-e59, 2022 | 17 | 2022 |
| Optimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor ED Tetzlaff, MP Davey Journal of the advanced practitioner in oncology 4 (4), 238, 2013 | 17 | 2013 |
| Thromboembolism in gastrointestinal cancers ED Tetzlaff, JD Cheng, JA Ajani Gastrointestinal Cancer Research: GCR 2 (6), 267, 2008 | 15 | 2008 |
| Emerging drugs in the treatment of advanced gastric cancer ED Tetzlaff, P Cen, JA Ajani Expert Opinion on Emerging Drugs 13 (1), 135-144, 2008 | 14 | 2008 |
| Clinical oncology practice 2015: Preparing for the future MP Kosty, AK Acheson, ED Tetzlaff American Society of Clinical Oncology Educational Book 35 (1), e622-e627, 2015 | 13 | 2015 |
| SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS). S Movva, M von Mehren, EA Handorf, JA Morgan, M Nathenson, ... Journal of Clinical Oncology 38 (15_suppl), 11544-11544, 2020 | 12 | 2020 |
| Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor ED Tetzlaff, JA Ajani International journal of gastrointestinal cancer 36, 55-58, 2005 | 12 | 2005 |
Jaffer AjaniUT M. D. Anderson Cancer CenterVerified email at mdanderson.org
